Summary & Overview
HCPCS J1955: Injection, Levocarnitine, 1 gm
HCPCS Level II code J1955 denotes a 1 gm unit of injectable levocarnitine, a parenteral medication used to treat carnitine deficiency and related metabolic conditions. This code matters nationally because injectable specialty drugs are billed across inpatient and outpatient settings and influence drug spend, utilization management, and prior authorization workflows for payers and providers.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a clear explanation of what J1955 represents clinically and operationally, the typical sites of service where the drug is administered, and the payer landscape relevant to coverage and billing practices. The publication also summarizes benchmarks for utilization and reimbursement where available, highlights recent policy or coverage updates affecting injectable drug billing, and provides clinical context around levocarnitine use.
This summary equips coding professionals, revenue cycle managers, and policy analysts with the essential facts about HCPCS Level II code J1955, so they can interpret billing records, align documentation with payer requirements, and understand where to look for coverage guidance and utilization controls.
Billing Code Overview
HCPCS Level II code J1955 represents an injection of levocarnitine, billed per 1 gm unit. The service is a parenteral medication administration involving intravenous or intramuscular injection of levocarnitine indicated for treatment of documented or suspected carnitine deficiency.
Service type: Medication administration / injectable drug
Typical site of service: Hospital inpatient, hospital outpatient, clinic, or infusion center, depending on clinical setting and ordering practitioner.
Data not available in the input for associated taxonomies, ICD-10 diagnoses, or related codes.
Clinical & Coding Specifications
Clinical Context
A typical patient is a pediatric or adult with documented primary or secondary carnitine deficiency who requires parenteral supplementation with levocarnitine (L-carnitine). The patient presents to an outpatient infusion center, hospital inpatient ward, or emergency department for administration of J1955 (injection, levocarnitine, per 1 gm). The clinical workflow includes physician order for dosage based on weight and severity, pharmacist verification and preparation of the sterile injectable product, nursing insertion of an intravenous peripheral or existing central line, administration over the prescribed infusion time, monitoring for infusion reactions or gastrointestinal intolerance, and documentation of lot number, NDC if required, and amount administered (grams). Typical visits include metabolic clinic follow-up for inborn errors of metabolism (e.g., primary carnitine transporter deficiency), oncology patients with secondary deficiency, or critically ill patients with malnutrition. Billing uses unitization of J1955 per 1 gram with appropriate diagnosis linkage and any clinically applicable modifier(s).
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
JW | Drug discarded/unused portion | When part of a multi-dose vial is discarded and payer requires reporting of discarded biologic drug. |